: The AMEDEO Literature Guide

Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

HIV Infection

Free Subscription

Articles published in J Acquir Immune Defic Syndr
Retrieve available abstracts of 486 articles:
HTML format
Text format

Single Articles

April 2010

JONES R , Nelson M, Low E, Atkins M, et al
Re-emergent Hepatitis C Viremia After Apparent Clearance in HIV-Positive Men Who Have Sex With Men: Reinfection or Late Recurrence?
J Acquir Immune Defic Syndr. 2010;53:547-50.
PubMed Text format Related articles

TAN CK , Hung CC, Lai CC, Liao CH, et al
Diagnosis of Active Tuberculosis by Enzyme-Linked Immunospot Assay for Interferon-gamma in HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2010;53:546-7.
PubMed Text format Related articles

PROTOPOPESCU C , Roux P, Carrieri MP, Katlama C, et al
Prolonged Medically Recorded Treatment Interruptions Among HIV-Infected Patients on Highly Active Antiretroviral Therapy With Controlled Viremia: When Physicians Have to Juggle Patient Negotiation and Guidelines.
J Acquir Immune Defic Syndr. 2010;53:544-545.
PubMed Text format Related articles

March 2010

HOFFMAN RM , Black V, Technau K, van der Merwe KJ, et al
Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

EMMETT SD , Cunningham CK, Mmbaga BT, Kinabo GD, et al
Predicting Virologic Failure Among HIV-1-Infected Children Receiving Antiretroviral Therapy in Tanzania: a Cross-Sectional Study.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

DEFFENBACHER KE , Iqbal J, Liu Z, Fu K, et al
Recurrent Chromosomal Alterations in Molecularly Classified AIDS-Related Lymphomas: An Integrated Analysis of DNA Copy Number and Gene Expression.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

CHRISTOPOULOS KA , Schackman BR, Lee G, Green RA, et al
Results From a New York City Emergency Department Rapid HIV Testing Program.
J Acquir Immune Defic Syndr. 2010;53:420-422.
PubMed Text format Related articles

BAEKKEN M , Manner I, Ueland T, Froland SS, et al
Osteoprotegrin and Soluble Tumor Necrosis Factor Receptor 1 Are Associated With Microalbuminuria in Nontreated HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2010;53:419-420.
PubMed Text format Related articles

SONG JY , Lee JS, Jung HW, Choi HJ, et al
Herpes Zoster Among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Korean HIV Cohort Study.
J Acquir Immune Defic Syndr. 2010;53:417-8.
PubMed Text format Related articles

KEW MC , Smuts H, Stewart A
Does HIV Infection Enhance the Hepatocarcinogenic Potential of Chronic Hepatitis B Virus Infection?
J Acquir Immune Defic Syndr. 2010;53:413-4.
PubMed Text format Related articles

RUPP D , Geuenich S, Keppler OT
Poor Performance of Bioinformatics Programs for Genotypic Prediction of Coreceptor Usage of HIV-1 Group O Isolates.
J Acquir Immune Defic Syndr. 2010;53:412-3.
PubMed Text format Related articles

KOBLIN BA , Bonner S, Hoover DR, Xu G, et al
A Randomized Trial of Enhanced HIV Risk-Reduction and Vaccine Trial Education Interventions Among HIV-Negative, High-Risk Women Who Use Noninjection Drugs: The UNITY Study.
J Acquir Immune Defic Syndr. 2010;53:378-87.
PubMed Text format Related articles Abstract available

February 2010

HOWARD AA , Hoover DR, Anastos K, Wu X, et al
The Effects of Opiate Use and Hepatitis C Virus Infection on Risk of Diabetes Mellitus in the Women's Interagency HIV Study.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

SCHACKER TW , Bosch RJ, Bennett K, Pollard R, et al
Measurement of Naive CD4 Cells Reliably Predicts Potential for Immune Reconstitution in HIV.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

LIEB S , White S, Grigg BL, Thompson DR, et al
Estimated HIV Incidence, Prevalence, and Mortality Rates Among Racial/Ethnic Populations of Men Who Have Sex with Men, Florida.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

WILSON TE , Jean-Louis G, Schwartz R, Golub ET, et al
HIV Infection and Women's Sexual Functioning.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

WEVER K , van Agtmael MA, Carr A
Incomplete Reversibility of Tenofovir-Related Renal Toxicity in HIV-Infected Men.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

BELL C , Metsch LR, Vogenthaler N, Cardenas G, et al
Never in Care: Characteristics of HIV-Infected Crack Cocaine Users in 2 US Cities Who Have Never Been to Outpatient HIV Care.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

PROMADEJ-LANIER N , Hanson DL, Srinivasan P, Luo W, et al
Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

MANTINA H , Wiggill TM, Carmona S, Perner Y, et al
Characterization of Lymphomas in a High Prevalence HIV Setting.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

LAMPE FC , Harding R, Smith CJ, Phillips AN, et al
Physical and Psychological Symptoms and Risk of Virologic Rebound Among Patients With Virologic Suppression on Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

DEOK-JONG YOO S , Worodria W, Davis JL, Cattamanchi A, et al
The Prevalence and Clinical Course of HIV-Associated Pulmonary Cryptococcosis in Uganda.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

VIEILLARD V , Fausther-Bovendo H, Samri A, Debre P, et al
Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

SCOTT-ALGARA D , Rouzioux C, Blanche S, Burgard M, et al
In Untreated HIV-1-Infected Children, PBMC-Associated HIV DNA Levels and Cell-Free HIV RNA Levels Are Correlated to Distinct T-lymphocyte Populations.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

DAU B , Ayers D, Singer J, Richard Harrigan P, et al
Connection Domain Mutations in Treatment-Experienced Patients in the OPTIMA Trial.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

CHEN YJ , Huang YH, Chuang SY, Kao DY, et al
Molecular Epidemiology of HIV-1 Subtype B, CRF01_AE, and CRF07_BC Infection Among Injection Drug Users in Taiwan.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

HILLIS SD , Phd EK, Akatova N, Kissin DM, et al
Antiretroviral Prophylaxis to Prevent Perinatal HIV Transmission in St. Petersburg, Russia: Too Little, Too Late.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

PARA MF , Schouten J, Rosenkranz SL, Yu S, et al
Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

ZAJDENVERG R , Podsadecki TJ, Badal-Faesen S, Andrade-Villanueva J, et al
Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1-Infected Subjects at 48 Weeks.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

TOWNER W , Lalezari J, Sension MG, Wohlfeiler M, et al
Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

GUARALDI G , Stentarelli C, Orlando G, Zona S, et al
Nonalcoholic Fatty Liver Disease in HIV-Infected Persons: Epidemiology and the Role of Nucleoside Reverse Transcriptase Inhibitors.
J Acquir Immune Defic Syndr. 2010;53:278.
PubMed Text format Related articles

CRUM-CIANFLONE N , Dilay A, Collins G, Asher D, et al
Reply to "Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons".
J Acquir Immune Defic Syndr. 2010;53:278-81.
PubMed Text format Related articles

YE Y , Zeng Y, Li X, Zhang S, et al
HIV Infection: An Independent Risk Factor of Peripheral Arterial Disease.
J Acquir Immune Defic Syndr. 2010;53:276-8.
PubMed Text format Related articles

KHEIRANDISH P , Seyedalinaghi SA, Hosseini M, Jahani MR, et al
Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention in Tehran, Iran.
J Acquir Immune Defic Syndr. 2010;53:273-275.
PubMed Text format Related articles Abstract available

KACANEK D , Jacobson DL, Spiegelman D, Wanke C, et al
Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the nutrition for healthy living study.
J Acquir Immune Defic Syndr. 2010;53:266-72.
PubMed Text format Related articles Abstract available

FISCHER MJ , Wyatt CM, Gordon K, Gibert CL, et al
Hepatitis C and the Risk of Kidney Disease and Mortality in Veterans With HIV.
J Acquir Immune Defic Syndr. 2010;53:222-226.
PubMed Text format Related articles Abstract available

WILLIG JH , Echevarria J, Westfall AO, Iglesias D, et al
Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for Zidovudine weight-based dosing.
J Acquir Immune Defic Syndr. 2010;53:215-21.
PubMed Text format Related articles Abstract available

JOAO EC , Calvet GA, Krauss MR, Freimanis Hance L, et al
Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study.
J Acquir Immune Defic Syndr. 2010;53:176-185.
PubMed Text format Related articles Abstract available

FENG Y , Wu Z, Detels R
Evolution of men who have sex with men community and experienced stigma among men who have sex with men in Chengdu, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S98-103.
PubMed Text format Related articles Abstract available

WANG Y , Jiang Y, Lu L, Wang G, et al
Microbicide acceptability and associated factors among female sex workers and male clients in kaiyuan county, yunnan province, china.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S93-7.
PubMed Text format Related articles Abstract available

ZHANG H , Wu Z, Zheng Y, Wang J, et al
A pilot intervention to increase condom use and HIV testing and counseling among men who have sex with men in Anhui, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S88-92.
PubMed Text format Related articles Abstract available

ZOU H , Wu Z, Yu J, Li M, et al
Sexual risk behaviors and HIV infection among men who have sex with men who use the internet in Beijing and Urumqi, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S81-7.
PubMed Text format Related articles Abstract available

FENG Y , Wu Z, Detels R, Qin G, et al
HIV/STD prevalence among men who have sex with men in Chengdu, China and associated risk factors for HIV infection.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S74-80.
PubMed Text format Related articles Abstract available

XIAO Y , Sun J, Li C, Lu F, et al
Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S66-73.
PubMed Text format Related articles Abstract available

WANG L , Liu W, Wang L, Wang Y, et al
HIV prevalence among pulmonary tuberculosis patients in Guangxi, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S61-5.
PubMed Text format Related articles Abstract available

ZHANG G , Wong M, Yi P, Xu J, et al
HIV-1 and STIs prevalence and risk factors of miners in mining districts of Yunnan, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S54-60.
PubMed Text format Related articles Abstract available

LI Y , Detels R, Lin P, Fu X, et al
Prevalence of HIV and STIs and associated risk factors among female sex workers in Guangdong Province, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S48-53.
PubMed Text format Related articles Abstract available

LI N , Wang Z, Sun D, Zhu Q, et al
HIV among plasma donors and other high-risk groups in Henan, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S41-7.
PubMed Text format Related articles Abstract available

ZHAO M , Geng W, Jiang Y, Han X, et al
The associations of hA3G and hA3B mRNA levels with HIV disease progression among HIV-infected individuals of China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S4-9.
PubMed Text format Related articles Abstract available

JIA M , Luo H, Ma Y, Wang N, et al
The HIV epidemic in Yunnan Province, China, 1989-2007.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S34-40.
PubMed Text format Related articles Abstract available

HAN X , Dai D, Zhao B, Liu J, et al
Genetic and epidemiologic characterization of HIV-1 infection In Liaoning Province, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S27-33.
PubMed Text format Related articles Abstract available

ZHOU Z , Meyers K, Li X, Chen Q, et al
Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S15-22.
PubMed Text format Related articles Abstract available

XU T , Wu Z, Yan Z, Rou K, et al
Measuring health-related quality of life in children living in HIV/AIDS-affected families in rural areas in Yunnan, China: Preliminary reliability and validity of the Chinese version of PedsQL 4.0 generic core scales.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S111-5.
PubMed Text format Related articles Abstract available

XU T , Wu Z, Duan S, Han W, et al
The situation of children affected by HIV/AIDS in Southwest China: Schooling, physical health, and interpersonal relationships.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S104-10.
PubMed Text format Related articles Abstract available

LIAO L , Xing H, Shang H, Li J, et al
The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S10-4.
PubMed Text format Related articles Abstract available

WU Z , Wang Y
Introduction: China meets new AIDS challenges.
J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S1-3.
PubMed Text format Related articles

January 2010

LABARGA P , Vispo E, Barreiro P, Rodriguez-Novoa S, et al
Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/HCV-Coinfected Patients With Prior Nonresponse or Relapse.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

OSINUSI A , Rasimas JJ, Bishop R, Proschan M, et al
HIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

FALUTZ J , Potvin D, Mamputu JC, Assaad H, et al
Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

HENDRICKSON SL , Jabs DA, Van Natta M, Lewis RA, et al
Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

WYATT CM , Hoover DR, Shi Q, Seaberg E, et al
Microalbuminuria Is Associated With All-Cause and AIDS Mortality in Women With HIV Infection.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

SIERRA-MADERO J , Villasis-Keever A, Mendez P, Mosqueda-Gomez JL, et al
Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

NIE J , Zhang C, Liu W, Wu X, et al
Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 CRF01_AE env Molecular Clones From Infections in China.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

COOPER V , Horne R, Gellaitry G, Vrijens B, et al
The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

CRAWFORD KW , Li C, Keung A, Su Z, et al
Pharmacokinetic/Pharmacodynamic Modeling of the Antiretroviral Activity of the CCR5 Antagonist Vicriviroc in Treatment Experienced HIV-Infected Subjects (ACTG Protocol 5211).
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

KATZ IT , Shapiro R, Li D, Govindarajulu U, et al
Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

CHANG TL , Klepper A, Ding J, Garber J, et al
Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of Human Immunodeficiency Virus Type 1 Isolates.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

HURT CB , Matthews DD, Calabria MS, Green KA, et al
Sex with Older Partners Is Associated With Primary HIV Infection Among Men Who Have Sex With Men in North Carolina.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

FISER AL , Lin YL, Portales P, Mettling C, et al
Pairwise Comparison of Isogenic HIV-1 Viruses: R5 Phenotype Replicates More Efficiently Than X4 Phenotype in Primary CD4+ T Cells Expressing Physiological Levels of CXCR4.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

WANG H , Zhuang K, Liu L, Tang Z, et al
Acute Infection of Chinese Macaques by a CCR5-Tropic SHIV Carrying a Primary HIV-1 Subtype B' Envelope.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

BROGLY SB , Foca M, Deville JG, Mirochnick M, et al
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
J Acquir Immune Defic Syndr. 2010;53:154-7.
PubMed Text format Related articles

ZACCARELLI M , Antinori A, Cozzi-Lepri A, Mussini C, et al
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
J Acquir Immune Defic Syndr. 2010;53:150-1.
PubMed Text format Related articles

BRADY MT , Oleske JM, Williams PL, Elgie C, et al
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
J Acquir Immune Defic Syndr. 2010;53:86-94.
PubMed Text format Related articles Abstract available

TUBOI SH , Pacheco AG, Harrison LH, Stone RA, et al
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
J Acquir Immune Defic Syndr. 2010;53:70-7.
PubMed Text format Related articles Abstract available

December 2009

WILSON IB , Barton Laws M, Safren SA, Lee Y, et al
Provider-Focused Intervention Increases Adherence-Related Dialogue but Does Not Improve Antiretroviral Therapy Adherence in Persons With HIV.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ERIKSTRUP C , Kronborg G, Lohse N, Rye Ostrowski S, et al
T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BEGIER EM , Bennani Y, Forgione L, Punsalang A, et al
Undiagnosed HIV Infection Among New York City Jail Entrants, 2006: Results of a Blinded Serosurvey.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MOLINA JM , Andrade-Villanueva J, Echevarria J, Chetchotisakd P, et al
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Stud
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ZHOU S , Zhao Y, He Y, Li H, et al
Hepatitis B and Hepatitis C Seroprevalence in Children Receiving Antiretroviral Therapy for Human Immunodeficiency Virus-1 Infection in China, 2005-2009.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GOETZ MB , Leduc R, Wyman N, Kostman JR, et al
HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BECKWITH CG , Liu T, Bazerman LB, Delong AK, et al
HIV Risk Behavior Before and After HIV Counseling and Testing in Jail: A Pilot Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GLASS TR , Battegay M, Cavassini M, De Geest S, et al
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KIWANUKA N , Robb M, Laeyendecker O, Kigozi G, et al
HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ASMUTH DM , Goodrich J, Cooper DA, Haubrich R, et al
CD4+ T-Cell Restoration After 48 Weeks in the Maraviroc Treatment-Experienced Trials MOTIVATE 1 and 2.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FREIBERG MS , McGinnis KA, Kraemer K, Samet JH, et al
The Association Between Alcohol Consumption and Prevalent Cardiovascular Diseases Among HIV-Infected and HIV-Uninfected Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LIGHTFOOT M , Rotheram-Borus MJ, Comulada WS, Reddy VS, et al
Efficacy of Brief Interventions in Clinical Care Settings for Persons Living With HIV.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

IARIKOV DE , Irizarry-Acosta M, Martorell C, Rauch CA, et al
Use of HIV Resistance Testing After Prolonged Treatment Interruption.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ENGELS EA , Pfeiffer RM, Landgren O, Moore RD, et al
Immunologic and Virologic Predictors of AIDS-Related Non-Hodgkin Lymphoma in the Highly Active Antiretroviral Therapy Era.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

RAYMOND S , Delobel P, Mavigner M, Ferradini L, et al
Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PANOS G , Farouk L, Stebbing J, Holmes P, et al
Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV.
J Acquir Immune Defic Syndr. 2009;52:525-7.
PubMed Text format Related articles

SIMONI JM , Huh D, Frick PA, Pearson CR, et al
Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial.
J Acquir Immune Defic Syndr. 2009;52:465-473.
PubMed Text format Related articles Abstract available

BOGER MS , Shintani A, Redhage LA, Mitchell V, et al
Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
J Acquir Immune Defic Syndr. 2009;52:480-7.
PubMed Text format Related articles Abstract available

BOLIVAR H , Geffin R, Manzi G, Fischl MA, et al
The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain.
J Acquir Immune Defic Syndr. 2009;52:659-61.
PubMed Text format Related articles

TORNERO C , Mafe C
Varenicline and Antiretroviral Therapy in Patients With HIV.
J Acquir Immune Defic Syndr. 2009;52:656.
PubMed Text format Related articles

ESTEBAN PM , Thahn TG, Bravo JF, Roca LK, et al
Malnutrition Associated With Increased Risk of Peripheral Neuropathy in Peruvian Children With HIV Infection.
J Acquir Immune Defic Syndr. 2009;52:656-658.
PubMed Text format Related articles

STEVENS WS , Wallis CL, Sanne I, Venter F, et al
Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?
J Acquir Immune Defic Syndr. 2009;52:655-6.
PubMed Text format Related articles

BOGART LM , Wagner G, Galvan FH, Banks D, et al
Conspiracy Beliefs About HIV Are Related to Antiretroviral Treatment Nonadherence Among African American Men With HIV.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WOMACK JA , Scherzer R, Cole SR, Fennie K, et al
Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.
J Acquir Immune Defic Syndr. 2009;52:581-7.
PubMed Text format Related articles Abstract available

MUSOKE PM , Barlow-Mosha L, Bagenda D, Mudiope P, et al
Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.
J Acquir Immune Defic Syndr. 2009;52:560-8.
PubMed Text format Related articles Abstract available

HAN J , Wang B, Han N, Zhao Y, et al
CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients.
J Acquir Immune Defic Syndr. 2009;52:553-9.
PubMed Text format Related articles Abstract available

PEERSMAN G , Ferguson L, Torres MA, Smith S, et al
Increasing civil society participation in the national HIV response: the role of UNGASS reporting.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S97-103.
PubMed Text format Related articles Abstract available

PEERSMAN G , Rugg D, Erkkola T, Kiwango E, et al
Are the investments in national HIV monitoring and evaluation systems paying off?
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S87-96.
PubMed Text format Related articles Abstract available

WARNER-SMITH M , Rugg D, Frescura L, Moussavi S, et al
Monitoring the 2001 Declaration of Commitment on HIV/AIDS.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S77-86.
PubMed Text format Related articles Abstract available

RUGG D , Marais H, Carael M, De Lay P, et al
Are we on course for reporting on the Millennium Development Goals in 2015?
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S69-76.
PubMed Text format Related articles Abstract available

MAHY M , Warner-Smith M, Stanecki KA, Ghys PD, et al
Measuring the impact of the global response to the AIDS epidemic: challenges and future directions.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S152-9.
PubMed Text format Related articles Abstract available

ADAM PC , de Wit JB, Toskin I, Mathers BM, et al
Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S143-51.
PubMed Text format Related articles Abstract available

MATHERS BM , Degenhardt L, Adam P, Toskin I, et al
Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S132-42.
PubMed Text format Related articles Abstract available

TAKEI T , Amin NA, Schmid G, Dhingra-Kumar N, et al
Progress in global blood safety for HIV.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S127-31.
PubMed Text format Related articles Abstract available

IZAZOLA-LICEA JA , Wiegelmann J, Aran C, Guthrie T, et al
Financing the response to HIV in low-income and middle-income countries.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S119-26.
PubMed Text format Related articles Abstract available

CARAEL M , Marais H, Polsky J, Mendoza A, et al
Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S111-8.
PubMed Text format Related articles Abstract available

GRUSKIN S , Ferguson L, Peersman G, Rugg D, et al
Human rights in the global response to HIV: findings from the 2008 United Nations General Assembly Special Session Reports.
J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S104-10.
PubMed Text format Related articles Abstract available

November 2009

BERNSTEIN KT , Marcus JL, Nieri G, Philip SS, et al
Rectal Gonorrhea and Chlamydia Reinfection Is Associated With Increased Risk of HIV Seroconversion.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KUMTA S , Lurie M, Weitzen S, Jerajani H, et al
Bisexuality, Sexual Risk Taking, and HIV Prevalence Among Men Who Have Sex With Men Accessing Voluntary Counseling and Testing Services in Mumbai, India.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MOSIMANEOTSILE B , Mathoma A, Chengeta B, Nyirenda S, et al
Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

OTITI-SENGERI J , Colebunders R, Kempen JH, Ronald A, et al
The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals With Visual Loss in Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARSHALL BD , Shannon K, Kerr T, Zhang R, et al
Survival Sex Work and Increased HIV Risk Among Sexual Minority Street-Involved Youth.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

TAIWO BO , Idoko JA, Welty LJ, Otoh I, et al
Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited Setting.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PATTANAPANYASAT K , Noulsri E, Lerdwana S, Sukapirom K, et al
The Use of Glutaraldehyde-Fixed Chicken Red Blood Cells as Counting Beads for Performing Affordable Single-Platform CD4+ T-Lymphocyte Count in HIV-1-Infected Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NABATIYAN A , Baumann MA, Parpia Z, Kelso D, et al
A Lateral Flow-Based Ultra-Sensitive p24 HIV Assay Utilizing Fluorescent Microparticles.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DECKER MR , Miller E, Raj A, Saggurti N, et al
Indian Men's Use of Commercial Sex Workers: Prevalence, Condom Use, and Related Gender Attitudes.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN GRIENSVEN F , Varangrat A, Wimonsate W, Tanpradech S, et al
Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003-2007.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN VONDEREN MG , Blumer RM, Hassink EA, Sutinen J, et al
Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

YIN MT , Lu D, Cremers S, Tien PC, et al
Short-Term Bone Loss in HIV-Infected Premenopausal Women.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SAITOH A , Capparelli E, Aweeka F, Sarles E, et al
CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1-Infected Children Receiving Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BREILH D , Djabarouti S, Trimoulet P, Le Bail B, et al
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
J Acquir Immune Defic Syndr. 2009;52:428-30.
PubMed Text format Related articles

FUMAZ CR , Gonzalez-Garcia M, Borras X, Ferrer MJ, et al
Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress.
J Acquir Immune Defic Syndr. 2009;52:427-8.
PubMed Text format Related articles

ATUN R , Kazatchkine M
Promoting country ownership and stewardship of health programs: The global fund experience.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S67-8.
PubMed Text format Related articles Abstract available

HARRINGTON M
Community involvement in HIV and tuberculosis research.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S63-6.
PubMed Text format Related articles Abstract available

RABKIN M , El-Sadr WM, De Cock KM
The impact of HIV scale-up on health systems: A priority research agenda.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S6-11.
PubMed Text format Related articles Abstract available

NASH D , Elul B, Rabkin M, Tun M, et al
Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S58-62.
PubMed Text format Related articles Abstract available

BRAITSTEIN P , Einterz RM, Sidle JE, Kimaiyo S, et al
"Talkin' about a revolution": How electronic health records can facilitate the scale-up of HIV care and treatment and catalyze primary care in resource-constrained settings.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S54-7.
PubMed Text format Related articles Abstract available

MYER L , Akugizibwe P
Impact of HIV treatment scale-up on women's reproductive health care and reproductive rights in Southern Africa.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S52-3.
PubMed Text format Related articles Abstract available

PARKER RG
Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S49-51.
PubMed Text format Related articles Abstract available

SHIFFMAN J , Berlan D, Hafner T
Has aid for AIDS raised all health funding boats?
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S45-8.
PubMed Text format Related articles Abstract available

LIEBERMAN S , Gottret P, Yeh E, de Beyer J, et al
International health financing and the response to AIDS.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S38-44.
PubMed Text format Related articles Abstract available

EMBREY M , Hoos D, Quick J
How AIDS funding strengthens health systems: progress in pharmaceutical management.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S34-7.
PubMed Text format Related articles Abstract available

JUSTMAN JE , Koblavi-Deme S, Tanuri A, Goldberg A, et al
Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S30-3.
PubMed Text format Related articles Abstract available

LEVINE R , Oomman N
Global HIV/AIDS funding and health systems: Searching for the win-win.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S3-5.
PubMed Text format Related articles Abstract available

DOHRN J , Nzama B, Murrman M
The impact of HIV scale-up on the role of nurses in South Africa: Time for a new approach.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S27-9.
PubMed Text format Related articles Abstract available

ABRAMS EJ , El-Sadr WM
Lessons from Harlem: Relevance to a global epidemic.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S24-6.
PubMed Text format Related articles Abstract available

SHERR K , Pfeiffer J, Mussa A, Vio F, et al
The role of nonphysician clinicians in the rapid expansion of HIV care in Mozambique.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S20-3.
PubMed Text format Related articles Abstract available

KAMARULZAMAN A
Impact of HIV prevention programs on drug users in Malaysia.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S17-9.
PubMed Text format Related articles Abstract available

HIV scale-up and global health systems. Proceedings of a meeting. September 2008. Bellagio, Italy.
J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S1-68.
PubMed Text format Related articles

October 2009

WANG R , Lagakos SW
On the Use of Adjusted Cross-Sectional Estimators of HIV Incidence.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHEN JY , Ogwu AC, Svab P, Lockman S, et al
Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SHAFFER DN , Ngetich IK, Bautista CT, Sawe FK, et al
HIV-1 Incidence Rates and Risk Factors in Agricultural Workers and Dependents in Rural Kenya: 36-Month Follow-Up of the Kericho HIV Cohort Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BOULDOUYRE MA , Charreau I, Marchou B, Tangre P, et al
Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KAFULAFULA G , Hoover DR, Taha TE, Thigpen M, et al
Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality with Early Weaning in HIV-1-Uninfected Children Born to HIV-Infected Women in Malawi.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SCHERRER AU , von Wyl V, Fux CA, Opravil M, et al
Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

YEHIA BR , Fleishman JA, Hicks PL, Ridore M, et al
Inpatient Health Services Utilization Among HIV-Infected Adult Patients in Care 2002-2007.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN TIENEN C , van der Loeff MS, Zaman SM, Vincent T, et al
Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BUCHACZ K , Baker RK, Young B, Brooks JT, et al
Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FATKENHEUER G , Hoffmann C, Slim J, Rouzier R, et al
Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection is Safe and Tolerable.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

REID SE , Dai JY, Wang J, Sichalwe BN, et al
Pregnancy, Contraceptive Use, and HIV Acquisition in HPTN 039: Relevance for HIV Prevention Trials Among African Women.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FOX MP , Ive P, Long L, Maskew M, et al
High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HORBERG M , Tang B, Towner W, Silverberg M, et al
Impact of Tenofovir on Renal Function in HIV-Infected Antiretroviral Naive Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KHEIRANDISH P , Seyedalinaghi SA, Hosseini M, Jahani MR, et al
Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention, Tehran, Iran.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

OPRAVIL M , Klimkait T, Louvel S, Wolf E, et al
Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients with Lamivudine-resistant HIV-1 Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CAMPSMITH ML , Rhodes PH, Hall HI, Green TA, et al
Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BOUSHERI S , Burke C, Ssewanyana I, Harrigan R, et al
Infection With Different HIV Subtypes Is Associated With CD4 Activation-Associated Dysfunction and Apoptosis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LETANG E , Almeida JM, Miro JM, Ayala E, et al
Predictors of Immune Reconstitution Inflammatory Syndrome-Associated With Kaposi Sarcoma in Mozambique: A Prospective Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WALLIS C , Sanne I, Venter F, Mellors J, et al
Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CREEK TL , Kim A, Lu L, Bowen A, et al
Hospitalization and Mortality Among Primarily Non-breastfed Children During a Large Outbreak of Diarrhea and Malnutrition in Botswana, 2006.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ROSSI R , Nuzzo A, Guaraldi G, Orlando G, et al
The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infection.
J Acquir Immune Defic Syndr. 2009;52:303-4.
PubMed Text format Related articles

GOICOECHEA M , Smith D, May S, Mathews C, et al
Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication.
J Acquir Immune Defic Syndr. 2009;52:299-301.
PubMed Text format Related articles

September 2009

WILLIG JH , Echevarria J, Westfall AO, Iglesias D, et al
Durability of Initial Antiretroviral Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HOMSY J , Moore D, Barasa A, Were W, et al
Breastfeeding, Mother-to-Child HIV Transmission, and Mortality Among Infants Born to HIV-Infected Women on Highly Active Antiretroviral Therapy in Rural Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

AVIDAN NU , Goldstein D, Rozenberg L, McLaughlin M, et al
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

AUVERT B , Lissouba P, Cutler E, Zarca K, et al
Association of Oncogenic and Nononcogenic Human Papillomavirus With HIV Incidence.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GARRABOU G , Moren C Phd Student, Gallego-Escuredo JM Phd Student, Milinkovic A, et al
Genetic and Functional Mitochondrial Assessment of HIV-Infected Patients Developing HAART-Related Hyperlactatemia.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ONYANGO-MAKUMBI C , Bagenda D, Mwatha A, Omer SB, et al
Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAGENAS P , Williams VG, Piatak M Jr, Bess JW Jr, et al
Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SQUILLACE N , Zona S, Stentarelli C, Orlando G, et al
Detectable HIV Viral Load Is Associated With Metabolic Syndrome.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SINGH JC , Kuohung V, Palefsky JM
Efficacy of Trichloroacetic Acid in the Treatment of Anal Intraepithelial Neoplasia in HIV-Positive and HIV-Negative Men Who Have Sex With Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SHIELS MS , Cole SR, Kirk GD, Poole C, et al
A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VESSIERE A , Rousset D, Kfutwah A, Leoz M, et al
Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MAY S , Gamst A, Haubrich R, Benson C, et al
Pooled Nucleic Acid Testing to Identify Antiretroviral Treatment Failure During HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MAGNUS M , Jones K, Phillips G, Binson D, et al
Characteristics Associated With Retention Among African American and Latino Adolescent HIV-Positive Men: Results From the Outreach, Care, and Prevention to Engage HIV-Seropositive Young MSM of Color Special Project of National Significance Initiative.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WEINTROB AC , Grandits GA, Agan BK, Ganesan A, et al
Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HAISSMAN JM , Vestergaard LS, Sembuche S, Erikstrup C, et al
Plasma Cytokine Levels in Tanzanian HIV-1-Infected Adults and the Effect of Antiretroviral Treatment.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LEWDEN C , Thiebaut R, Boufassa F, Coulibaly A, et al
Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Cote d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GENG EH , Bangsberg DR, Musinguzi N, Emenyonu N, et al
Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BRAITSTEIN P , Ayuo P, Mwangi A, Wools-Kaloustian K, et al
Sustainability of First-Line Antiretroviral Regimens: Findings From a Large HIV Treatment Program in Western Kenya.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DORJGOCHOO T , Noel F, Deschamps MM, Theodore H, et al
Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SPRADLING PR , Richardson JT, Buchacz K, Moorman AC, et al
Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996-2007.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

COCKERHAM L , Scherzer R, Zolopa A, Rimland D, et al
Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

STOCKMAN JK , Campbell JC, Celentano DD
Sexual Violence and HIV Risk Behaviors Among a Nationally Representative Sample of Heterosexual American Women: The Importance of Sexual Coercion.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

JIN F , Prestage GP, Imrie J, Kippax SC, et al
Anal Sexually Transmitted Infections and Risk of HIV Infection in Homosexual Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARKS KM , Clarke RM, Bussel JB, Talal AH, et al
Risk Factors for Thrombocytopenia in HIV-Infected Persons in the Era of Potent Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VARGHESE V , Shahriar R, Rhee SY, Liu T, et al
Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

JIN X , Smith K, Chen RY, Ding G, et al
HIV Prevalence and Risk Behaviors Among Male Clients of Female Sex Workers in Yunnan, China.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HARRISON KM , Song R, Zhang X
Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KLEIN DB , Hurley LB, Horberg MA, Silverberg MJ, et al
Increased Rates of Appendicitis in HIV-Infected Men: 1991-2005.
J Acquir Immune Defic Syndr. 2009;52:139-40.
PubMed Text format Related articles

JINNOPAT P , Isarangkura-Na-Ayuthaya P, Utachee P, Kitagawa Y, et al
Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE Strains on Drug Susceptibility of Virus to Protease Inhibitors.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GURJAR SR , Mangaiarkarasi A, Ravi V, Ranga U, et al
Molecular Characterization of a Full-Length Genome of a HIV-2 Isolate From India.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MOFENSON LM
Prevention of Breast Milk Transmission of HIV: The Time Is Now.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles

LAEYENDECKER O , Redd AD, Lutalo T, Gray RH, et al
Frequency of Long-Term Nonprogressors in HIV-1 Seroconverters From Rakai Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MATTEELLI A , Saleri N, Villani P, Bonkoungou V, et al
Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis.
J Acquir Immune Defic Syndr. 2009;52:64-9.
PubMed Text format Related articles Abstract available

BAKER JV , Duprez D, Rapkin J, Hullsiek KH, et al
Untreated HIV infection and large and small artery elasticity.
J Acquir Immune Defic Syndr. 2009;52:25-31.
PubMed Text format Related articles Abstract available

TOZZI V , Balestra P, Salvatori MF, Vlassi C, et al
Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
J Acquir Immune Defic Syndr. 2009;52:56-63.
PubMed Text format Related articles Abstract available

VAN DER SNOEK EM , Amelink A, van der Ende ME, den Hollander JC, et al
Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.
J Acquir Immune Defic Syndr. 2009;52:141-3.
PubMed Text format Related articles

CHI BH , Giganti M, Mulenga PL, Limbada M, et al
CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.
J Acquir Immune Defic Syndr. 2009;52:125-31.
PubMed Text format Related articles Abstract available

SERRAINO D , Zucchetto A, Suligoi B, Bruzzone S, et al
Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study.
J Acquir Immune Defic Syndr. 2009;52:99-105.
PubMed Text format Related articles Abstract available

August 2009

SCHMALTZ CA , Sant'anna FM, Neves SC, Velasque LD, et al
Influence of HIV Infection on Mortality in a Cohort of Patients Treated for Tuberculosis in the Context of Wide Access to HAART, in Rio de Janeiro, Brazil.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KILEWO C , Karlsson K, Ngarina M, Massawe A, et al
Prevention of Mother-to-Child Transmission of HIV-1 Through Breastfeeding by Treating Mothers With Triple Antiretroviral Therapy in Dar es Salaam, Tanzania: The Mitra Plus Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN RIE A , Dow A, Mupuala A, Stewart P, et al
Neurodevelopmental Trajectory of HIV-Infected Children Accessing Care in Kinshasa, Democratic Republic of Congo.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

RUAN Y , Jia Y, Zhang X, Liang H, et al
Incidence of HIV-1, Syphilis, Hepatitis B, and Hepatitis C Virus Infections and Predictors Associated With Retention in a 12-Month Follow-Up Study Among Men Who Have Sex With Men in Beijing, China.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MCQUILLAN GM , Kruszon-Moran D, Granade T, Feldman JW, et al
Seroprevalence of Human Immunodeficiency Virus in the US Household Population Aged 18-49 Years: The National Health and Nutrition Examination Surveys, 1999-2006.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SHAH M , Variava E, Holmes CB, Coppin A, et al
Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARIE-EVE R , Petros I, Chutema P, Md RT, et al
Screening and Treating Cervical Cancer in HIV-Positive Women in Cambodia.
J Acquir Immune Defic Syndr. 2009;51:644-6.
PubMed Text format Related articles

SHANKARKUMAR U , Pawar A, Prabu G, Ghosh K, et al
Role of HLA Class I (HLA-A, B) and HLA Class II (HLA-DRB, DQB) in HIV-1 Patients With and Without Pulmonary Tuberculosis.
J Acquir Immune Defic Syndr. 2009;51:640-1.
PubMed Text format Related articles

SHORTER MM , Ostermann J, Crump JA, Tribble AC, et al
Characteristics of HIV Voluntary Counseling and Testing Clients Before and During Care and Treatment Scale-Up in Moshi, Tanzania.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WEISER SD , Fernandes KA, Brandson EK, Lima VD, et al
The Association Between Food Insecurity and Mortality Among HIV-Infected Individuals on HAART.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LEE GA , Schwarz JM, Patzek S, Kim S, et al
The Acute Effects of HIV Protease Inhibitors on Insulin Suppression of Glucose Production in Healthy HIV-Negative Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SITTA R , Lert F, Gueguen A, Spire B, et al
No Variability Across Centers in Adherence and Response to HAART in French Hospitals: Results From the ANRS-EN12-VESPA Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ELLIOTT-DESORBO DK , Martin S, Wolters PL
Stressful Life Events and Their Relationship to Psychological and Medical Functioning in Children and Adolescents With HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ANDERSON JS , Hoy J, Hillman R, Barnden M, et al
A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

AISSANI B , Ogwaro KM, Shrestha S, Tang J, et al
The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LOPARDO GD , Bissio E, Iannella MD, Crespo AD, et al
Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

IMAZ A , Del Saz SV, Ribas MA, Curran A, et al
Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KEMPF MC , Pisu M, Dumcheva A, Westfall AO, et al
Gender Differences in Discontinuation of Antiretroviral Treatment Regimens.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HSIEH YH , Rothman RE
Reply to the Letter Regarding "Impact of HIV Status on Outcome of Infectious Complications in Intravenous Drug Users".
J Acquir Immune Defic Syndr. 2009;51:507-8.
PubMed Text format Related articles

RAMOS CG , Barcelos NT
Does Episodic Antiretroviral Therapy Increase HIV Transmission Risk Compared With Continuous Therapy?
J Acquir Immune Defic Syndr. 2009;51:506.
PubMed Text format Related articles

MERTZ D , Viktorin N, Wolbers M, Fluckiger U, et al
Impact of HIV Status on Outcome of Infectious Complications in Intravenous Drug Users.
J Acquir Immune Defic Syndr. 2009;51:506-7.
PubMed Text format Related articles

HAMERS RL , Beer ID, Kaura H, van Vugt M, et al
Oral Fluid HIV Rapid Testing in Southern Africa Is Suitable for Population-Level Surveillance But May Not Be So for Individual Diagnosis (Invited Response to Scott et al: Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Improve
J Acquir Immune Defic Syndr. 2009;51:648-649.
PubMed Text format Related articles

SCOTT LE , Noble LD, Langeveldt M, Jentsch U, et al
Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Improve Access to Diagnosis in South Africa?
J Acquir Immune Defic Syndr. 2009;51:646-648.
PubMed Text format Related articles

TINCATI C , Bellistri GM, Casana M, Merlini E, et al
CD8+ Hyperactivation and Senescence Correlate With Early Carotid Intima-Media Thickness in HIV+ Patients With No Cardiovascular Disease.
J Acquir Immune Defic Syndr. 2009;51:642-644.
PubMed Text format Related articles

KRISHNA G , Moton A, Ma L, Martinho M, et al
Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.
J Acquir Immune Defic Syndr. 2009;51:437-44.
PubMed Text format Related articles Abstract available

NEL A , Smythe S, Young K, Malcolm K, et al
Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
J Acquir Immune Defic Syndr. 2009;51:416-23.
PubMed Text format Related articles Abstract available

GEFFEN N
Justice after AIDS denialism: should there be prosecutions and compensation?
J Acquir Immune Defic Syndr. 2009;51:454-5.
PubMed Text format Related articles

July 2009

BUSSE KH , Hadigan C, Chairez C, Alfaro RM, et al
Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARKOWITZ M , Nguyen BY, Gotuzzo E, Mendo F, et al
Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GRAHAM SM , Masese L, Gitau R, Mwakangalu D, et al
Increased Risk of Genital Ulcer Disease in Women During the First Month After Initiating Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARGOT NA , Enejosa J, Cheng AK, Miller MD, et al
Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naive Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HAWKINS CA , Chaplin B, Idoko J, Ekong E, et al
Clinical and Genotypic Findings in HIV-Infected Patients With the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

OCHIENG W , Sauermann U, Schulte R, Suh YS, et al
Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MBIDA AD , Sosso S, Flori P, Saoudin H, et al
Measure of Viral Load by Using the Abbott Real-Time HIV-1 Assay on Dried Blood and Plasma Spot Specimens Collected in 2 Rural Dispensaries in Cameroon.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BOFFITO M , Jackson A, Lamorde M, Back D, et al
Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MMIRO FA , Aizire J, Mwatha AK, Eshleman SH, et al
Predictors of Early and Late Mother-to-Child Transmission of HIV in a Breastfeeding Population: HIV Network for Prevention Trials 012 Experience, Kampala, Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WEINBERG A , Huang S, Fenton T, Patterson-Bartlett J, et al
Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LOWRANCE DW , Ndamage F, Kayirangwa E, Ndagije F, et al
Adult Clinical and Immunologic Outcomes of the National Antiretroviral Treatment Program in Rwanda During 2004-2005.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BEDIMO RJ , McGinnis KA, Dunlap M, Rodriguez-Barradas MC, et al
Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GREENGRASS V , Lohman B, Morris L, Plate M, et al
Assessment of the Low-Cost Cavidi ExaVir Load Assay for Monitoring HIV Viral Load in Pediatric and Adult Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ANDERSON JS , Walker J, Nolta JA, Bauer G, et al
Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN LUIN M , Gras L, Richter C, Ende ME, et al
Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MORSICA G , Bagaglio S, Cicconi P, Capobianchi MR, et al
Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BARSS P , Grivna M, Ganczak M, Bernsen R, et al
Effects of a Rapid Peer-based HIV/AIDS Educational Intervention on Knowledge and Attitudes of High School Students in a High-Income Arab Country.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WHITE DA , Scribner AN, Huang JV
A Comparison of Patient Acceptance of Fingerstick Whole Blood and Oral Fluid Rapid HIV Screening in an Emergency Department.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VALENTE TW , Zogg JB, Christensen S, Richardson J, et al
Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LI H , Chen X, Jin X, Liu Z, et al
Proliferation, But Not Interleukin 2 Production, of Gag-Specific CD8+ T Cells Is Associated With Low HIV Viremia and High CD4 Counts in HIV-1-Infected Chinese Individuals.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SMIT E , Bhattacharya S, Osman H, Taylor S, et al
Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman Assay.
J Acquir Immune Defic Syndr. 2009;51:364-5.
PubMed Text format Related articles

GUST DA , Wiegand RE, Para M, Chen RT, et al
HIV Testing Outside of the Study Among Men Who Have Sex With Men Participating in an HIV Vaccine Efficacy Trial.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

COSTANTINI A , Giuliodoro S, Butini L, Silvestri G, et al
Abnormalities of Erythropoiesis During HIV-1 Disease: A Longitudinal Analysis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WILSON DP
Modelling based on Australian HIV notifications data suggests homosexual age mixing is primarily assortative.
J Acquir Immune Defic Syndr. 2009;51:356-60.
PubMed Text format Related articles Abstract available

BARTOLO I , Casanovas J, Bastos R, Rocha C, et al
HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique.
J Acquir Immune Defic Syndr. 2009;51:323-31.
PubMed Text format Related articles Abstract available

APRIL MD , Walensky RP, Chang Y, Pitt J, et al
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.
J Acquir Immune Defic Syndr. 2009;51:310-6.
PubMed Text format Related articles Abstract available

LEBRECHT D , Venhoff AC, Kirschner J, Wiech T, et al
Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
J Acquir Immune Defic Syndr. 2009;51:258-63.
PubMed Text format Related articles Abstract available

TALBOT A , Machouf N, Thomas R, Marcotte S, et al
Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Safety at 24 Weeks in a Montreal Cohort.
J Acquir Immune Defic Syndr. 2009;51:362-364.
PubMed Text format Related articles

AIRO P , Scarsi M, Malagoli A, Carella G, et al
The Convenience of Flow Cytometry for HLA-B*5701 Screening to Prevent Abacavir Hypersensitivity Reactions.
J Acquir Immune Defic Syndr. 2009;51:361-2.
PubMed Text format Related articles

EHRHARDT AA , Sawires S, McGovern T, Peacock D, et al
Gender, empowerment, and health: what is it? How does it work?
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S96-S105.
PubMed Text format Related articles Abstract available

SHAWKY S , Soliman C, Kassak KM, Oraby D, et al
HIV surveillance and epidemic profile in the Middle East and North Africa.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S83-95.
PubMed Text format Related articles Abstract available

SAWIRES S , Birnbaum N, Abu-Raddad L, Szekeres G, et al
Twenty-five years of HIV: lessons for low prevalence scenarios.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S75-82.
PubMed Text format Related articles Abstract available

SHAWKY S , Soliman C, Sawires S
Gender and HIV in the Middle East and North Africa: lessons for low prevalence scenarios.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S73-4.
PubMed Text format Related articles

PEACOCK D , Stemple L, Sawires S, Coates TJ, et al
Men, HIV/AIDS, and human rights.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S119-25.
PubMed Text format Related articles Abstract available

DWORKIN SL , Kambou SD, Sutherland C, Moalla K, et al
Gendered empowerment and HIV prevention: policy and programmatic pathways to success in the MENA region.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S111-8.
PubMed Text format Related articles Abstract available

REMIEN RH , Chowdhury J, Mokhbat JE, Soliman C, et al
Gender and care: access to HIV testing, care, and treatment.
J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S106-10.
PubMed Text format Related articles Abstract available

June 2009

MEGAZZINI KM , Chintu N, Vermund SH, Redden DT, et al
Predictors of Rapid HIV Testing Acceptance and Successful Nevirapine Administration in Zambian Labor Wards.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MOORE ZS , McCoy S, Kuruc J, Hilton M, et al
Number of Named Partners and Number of Partners Newly Diagnosed With HIV Infection Identified by Persons With Acute Versus Established HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FISHER M , Moyle GJ, Shahmanesh M, Orkin C, et al
A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected Individuals.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LINAS BP , Losina E, Rockwell A, Walensky RP, et al
Improving Outcomes in State AIDS Drug Assistance Programs.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BANSI L , Turner J, Gilson R, Post F, et al
Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NDIAYE HD , Kane CT, Vidal N, Niama FR, et al
Surprisingly High Prevalence of Subtype C and Specific HIV-1 Subtype/CRF Distribution in Men Having Sex With Men in Senegal.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NUTTBROCK L , Hwahng S, Bockting W, Rosenblum A, et al
Lifetime Risk Factors for HIV/Sexually Transmitted Infections Among Male-to-Female Transgender Persons.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MICEK MA , Gimbel-Sherr K, Baptista AJ, Matediana E, et al
Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to Treatment.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LYNEN L , An S, Koole O, Thai S, et al
An Algorithm to Optimize Viral Load Testing in HIV-Positive Patients With Suspected First-Line Antiretroviral Therapy Failure in Cambodia.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KUATE S , Mikolajczyk RT, Forgwei GW, Tih PM, et al
Time Trends and Regional Differences in the Prevalence of HIV Infection Among Women Attending Antenatal Clinics in 2 Provinces in Cameroon.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DUMOND JB , Patterson KB, Pecha AL, Werner RE, et al
Maraviroc Concentrates in the Cervicovaginal Fluid and Vaginal Tissue of HIV-Negative Women.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SHAHMANESH M , Wayal S, Copas A, Patel V, et al
A Study Comparing Sexually Transmitted Infections and HIV Among Ex-Red-Light District and Non-Red-Light District Sex Workers After the Demolition of Baina Red-Light District.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NOVITSKY V , Wang R, Kebaabetswe L, Greenwald J, et al
Better Control of Early Viral Replication Is Associated With Slower Rate of Elicited Antiviral Antibodies in the Detuned Enzyme Immunoassay During Primary HIV-1C Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

AMMANN AJ
Optimal Versus Suboptimal Treatment for HIV-Infected Pregnant Women and HIV-Exposed Infants in Clinical Research Studies.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles

CHEN JH , Wong KH, Li P, Chan KC, et al
Molecular Epidemiological Study of HIV-1 CRF01_AE Transmission in Hong Kong.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ROBINSON-PAPP J , Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, et al
The Roles of Ethnicity and Antiretrovirals in HIV-Associated Polyneuropathy: A Pilot Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

POTARD V , Weiss L, Lamontagne F, Rouveix E, et al
Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1-Infected Patients in France Between 1997 and 2005.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KIGOZI IM , Dobkin LM, Martin JN, Geng EH, et al
Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DOMINGO P , Suarez-Lozano I, Torres F, Pomar V, et al
Bacterial Meningitis in HIV-1-Infected Patients in the Era of Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MACLACHLAN E , Mayer KH, Barnabas R, Sanchez J, et al
The Potential Role of Biomarkers in HIV Preventive Vaccine Trials: A Critical Review.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BROWN TT , McComsey GA, King MS, Qaqish RB, et al
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DOHERTY IA , Schoenbach VJ, Adimora AA
Sexual Mixing Patterns and Heterosexual HIV Transmission Among African Americans in the Southeastern United States.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ESHLEMAN SH , Khaki L, Laeyendecker O, Piwowar-Manning E, et al
Detection of Individuals With Acute HIV-1 Infection Using the ARCHITECT HIV Ag/Ab Combo Assay.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KUHN L , Semrau K, Ramachandran S, Sinkala M, et al
Mortality and Virologic Outcomes After Access to Antiretroviral Therapy Among a Cohort of HIV-Infected Women Who Received Single-Dose Nevirapine in Lusaka, Zambia.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GERMAN P , Parikh S, Lawrence J, Dorsey G, et al
Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LEHMAN DA , Chung MH, Mabuka JM, John-Stewart GC, et al
Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MORA S , Vigano A, Cafarelli L, Pattarino G, et al
Applicability of Quantitative Ultrasonography of the Radius and Tibia in HIV-Infected Children and Adolescents.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MABUKA JM , Mackelprang RD, Lohman-Payne B, Majiwa M, et al
CCR2-64I Polymorphism Is Associated With Lower Maternal HIV-1 Viral Load and Reduced Vertical HIV-1 Transmission.
J Acquir Immune Defic Syndr. 2009;51:235-237.
PubMed Text format Related articles

VAN GEERTRUYDEN JP , Colebunders R, D'alessandro U
HIV-1-Infected Individuals Traveling to Malaria Endemic Areas.
J Acquir Immune Defic Syndr. 2009;51:234-235.
PubMed Text format Related articles

WATTS DH , Huang S, Cohn SE, Smith L, et al
Repeat Pregnancies Among HIV-Infected Women Enrolled in Clinical Trial PACTG1022.
J Acquir Immune Defic Syndr. 2009;51:231-233.
PubMed Text format Related articles

OBIMBO EM , Wamalwa D, Richardson B, Mbori-Ngacha D, et al
Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality.
J Acquir Immune Defic Syndr. 2009;51:209-15.
PubMed Text format Related articles Abstract available

SOBIESZCYK ME , Xu G, Goodman K, Lucy D, et al
Engaging members of African American and Latino communities in preventive HIV vaccine trials.
J Acquir Immune Defic Syndr. 2009;51:194-201.
PubMed Text format Related articles Abstract available

KANKASA C , Carter RJ, Briggs N, Bulterys M, et al
Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility.
J Acquir Immune Defic Syndr. 2009;51:202-8.
PubMed Text format Related articles Abstract available

BASSETT IV , Wang B, Chetty S, Mazibuko M, et al
Loss to care and death before antiretroviral therapy in Durban, South Africa.
J Acquir Immune Defic Syndr. 2009;51:135-9.
PubMed Text format Related articles Abstract available

PALMISANO L , Galluzzo CM, Giuliano M
The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy.
J Acquir Immune Defic Syndr. 2009;51:233-4.
PubMed Text format Related articles

May 2009

ELLER MA , Eller LA, Ouma BJ, Thelian D, et al
Elevated Natural Killer Cell Activity Despite Altered Functional and Phenotypic Profile in Ugandans With HIV-1 Clade A or Clade D Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FRENCH AL , Gawel SH, Hershow R, Benning L, et al
Trends in Mortality and Causes of Death Among Women With HIV in the United States: A 10-Year Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PINEDA JA , Recio E, Camacho A, Macias J, et al
Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

TOWNER W , Klein D, Kerrigan HL, Follansbee S, et al
Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen: 24-Week Results of the CHEER Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

UY J , Armon C, Buchacz K, Wood K, et al
Initiation of HAART at Higher CD4 Cell Counts Is Associated With a Lower Frequency of Antiretroviral Drug Resistance Mutations at Virologic Failure.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

OSTER AM , Sullivan PS, Blair JM
Prevalence of Cervical Cancer Screening of HIV-Infected Women in the United States.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FERRY T , Raffi F, Collin-Filleul F, Dupon M, et al
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ALCANTARA S , Reece J, Amarasena T, Rose RD, et al
Thrombocytopenia Is Strongly Associated With Simian AIDS in Pigtail Macaques.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ALONSO-ARIAS R , Lopez-Vazquez A, Diaz-Pena R, Sampere A, et al
CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KHAN MR , Bolyard M, Sandoval M, Mateu-Gelabert P, et al
Social and Behavioral Correlates of Sexually Transmitted Infection- and HIV-Discordant Sexual Partnerships in Bushwick, Brooklyn, New York.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FENG L , Ding X, Lu R, Liu J, et al
High HIV Prevalence Detected in 2006 and 2007 Among Men Who Have Sex With Men in China's Largest Municipality: An Alarming Epidemic in Chongqing, China.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BENDAVID E , Wood R, Katzenstein DA, Bayoumi AM, et al
Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

JOHNSON BT , Scott-Sheldon LA, Smoak ND, Lacroix JM, et al
Behavioral Interventions for African Americans to Reduce Sexual Risk of HIV: A Meta-Analysis of Randomized Controlled Trials.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HANNA DB , Tsoi BW, Begier EM
Most Positive HIV Western Blot Tests Do Not Diagnose New Cases in New York City: Implications for HIV Testing Programs.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PACHECO AG , Tuboi SH, May SB, Moreira LF, et al
Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ANIS AH , Nosyk B, Sun H, Guh DP, et al
Quality of Life of Patients With Advanced HIV/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KITTIKRAISAK W , van Griensven F, Martin M, McNicholl J, et al
Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

TUBOI SH , Schechter M, McGowan CC, Cesar C, et al
Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MICOL R , Buchy P, Guerrier G, Duong V, et al
Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007).
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DECKER MR , Seage GR 3rd, Hemenway D, Raj A, et al
Intimate Partner Violence Functions as Both a Risk Marker and Risk Factor for Women's HIV Infection: Findings From Indian Husband-Wife Dyads.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHANTRY CJ , Israel-Ballard K, Moldoveanu Z, Peerson J, et al
Effect of Flash-Heat Treatment on Immunoglobulins in Breast Milk.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BRUYN G , Martinson NA, Nkala BD, Tshabangu N, et al
Uptake of Male Circumcision in an HIV Vaccine Efficacy Trial.
J Acquir Immune Defic Syndr. 2009;51:108-10.
PubMed Text format Related articles

MORSICA G , Bagaglio S, Uberti-Foppa C, Galli L, et al
Detection of Hepatitis C Mutants With Natural Resistance to NS3/4A Protease Inhibitors in HIV/HCV-Coinfected Individuals Treated With Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009;51:106-8.
PubMed Text format Related articles

BLOM-POTAR MC , Bugault F, Lambotte O, Delfraissy JF, et al
Soluble IL-7Ralpha (sCD127) and Measurement of IL-7 in the Plasma of HIV Patients.
J Acquir Immune Defic Syndr. 2009;51:104-5.
PubMed Text format Related articles

SOULIE C , Tubiana R, Simon A, Lambert-Niclot S, et al
Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma.
J Acquir Immune Defic Syndr. 2009;51:60-64.
PubMed Text format Related articles Abstract available

MALLOLAS J , Podzamczer D, Milinkovic A, Domingo P, et al
Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study.
J Acquir Immune Defic Syndr. 2009;51:29-36.
PubMed Text format Related articles Abstract available

RICCI E , Malacrida S, Zanchetta M, Montagna M, et al
Role of beta-Defensin-1 Polymorphisms in Mother-to-Child Transmission of HIV-1.
J Acquir Immune Defic Syndr. 2009;51:13-19.
PubMed Text format Related articles Abstract available

ALONSO M , Mazin R, Md RM, Cruz JR, et al
Preventing transfusion-transmitted HIV infection in Latin America and the Caribbean: issues associated with blood donor interviews and sex between men.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S67-72.
PubMed Text format Related articles Abstract available

CACERES CF , Mendoza W
The national response to the HIV/AIDS epidemic in Peru: accomplishments and gaps--a review.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S60-6.
PubMed Text format Related articles Abstract available

HALPERIN DT , de Moya EA, Perez-Then E, Pappas G, et al
Understanding the HIV epidemic in the Dominican Republic: a prevention success story in the Caribbean?
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S52-9.
PubMed Text format Related articles Abstract available

SANCHEZ J , Lama JR, Peinado J, Paredes A, et al
High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S47-51.
PubMed Text format Related articles Abstract available

STRATHDEE SA , Mausbach B, Lozada R, Staines-Orozco H, et al
Predictors of sexual risk reduction among Mexican female sex workers enrolled in a behavioral intervention study.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S42-6.
PubMed Text format Related articles Abstract available

SABIDO M , Giardina F, Hernandez G, Fernandez VH, et al
The UALE Project: decline in the incidence of HIV and sexually transmitted infections and increase in the use of condoms among sex workers in Guatemala.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S35-41.
PubMed Text format Related articles Abstract available

PAZ-BAILEY G , Morales-Miranda S, Jacobson JO, Gupta SK, et al
High rates of STD and sexual risk behaviors among Garifunas in Honduras.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S26-34.
PubMed Text format Related articles Abstract available

MAGIS-RODRIGUEZ C , Lemp G, Hernandez MT, Sanchez MA, et al
Going North: Mexican migrants and their vulnerability to HIV.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S21-5.
PubMed Text format Related articles Abstract available

HALL HI , Geduld J, Boulos D, Rhodes P, et al
Epidemiology of HIV in the United States and Canada: current status and ongoing challenges.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S13-20.
PubMed Text format Related articles Abstract available

GARCIA-CALLEJA JM , Rio CD, Souteyrand Y
HIV infection in the Americas: improving strategic information to improve response.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S1-3.
PubMed Text format Related articles

ESHUN-WILSON I , Plas HV, Prozesky HW, Zeier MD, et al
Combined antiretroviral treatment initiation during hospitalization: outcomes in South African adults.
J Acquir Immune Defic Syndr. 2009;51:105-6.
PubMed Text format Related articles

April 2009

SHLAY JC , Sharma S, Peng G, Gibert CL, et al
The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CRUM-CIANFLONE NF , Hullsiek KH, Marconi V, Weintrob A, et al
The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ELLIS GM , Page LC, Burman BE, Buskin S, et al
Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARTINEZ E , Arranz JA, Podzamczer D, Lonca M, et al
A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

OSTROW DG , Plankey MW, Cox C, Li X, et al
Specific Sex Drug Combinations Contribute to the Majority of Recent HIV Seroconversions Among MSM in the MACS.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

TRUONG HM , Kellogg T, Louie B, Klausner J, et al
Recent HIV-1 Infection Detection: Comparison of Incidence Estimates Derived by Laboratory Assays and Repeat Testing Data.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KWON JA , Iversen J, Maher L, Law MG, et al
The Impact of Needle and Syringe Programs on HIV and HCV Transmissions in Injecting Drug Users in Australia: A Model-Based Analysis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FIFE KH , Wu JW, Squires KE, Watts DH, et al
Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

TRIANT VA , Meigs JB, Grinspoon SK
Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ROBERTS SS , Martinez M, Covington DL Dr, Rode RA, et al
Lopinavir/Ritonavir in Pregnancy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ZETOLA NM , Bernstein KT, Wong E, Louie B, et al
Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs.
J Acquir Immune Defic Syndr. 2009;50:546-51.
PubMed Text format Related articles Abstract available

PETERS L , Mocroft A, Soriano V, Rockstroh JK, et al
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
J Acquir Immune Defic Syndr. 2009;50:457-63.
PubMed Text format Related articles Abstract available

HOWE R , Dillon S, Rogers L, Palmer B, et al
Phenotypic and functional characterization of HIV-1-specific CD4+CD8+ double-positive T cells in early and chronic HIV-1 infection.
J Acquir Immune Defic Syndr. 2009;50:444-56.
PubMed Text format Related articles Abstract available

GOGA AE , Van Wyk B, Doherty T, Colvin M, et al
Operational effectiveness of guidelines on complete breast-feeding cessation to reduce mother-to-child transmission of HIV: results from a prospective observational cohort study at routine prevention of mother-to-child transmission sites, South Africa.
J Acquir Immune Defic Syndr. 2009;50:521-8.
PubMed Text format Related articles Abstract available

EGGER S , Petoumenos K, Kamarulzaman A, Hoy J, et al
Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).
J Acquir Immune Defic Syndr. 2009;50:513-20.
PubMed Text format Related articles Abstract available

GANDHI M , Benet LZ, Bacchetti P, Kalinowski A, et al
Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
J Acquir Immune Defic Syndr. 2009;50:482-91.
PubMed Text format Related articles Abstract available

VAN GRIENSVEN J , Zachariah R, Rasschaert F, Reid T, et al
Discordant immunologic and virologic responses to antiretroviral therapy and associated mortality in a large treatment program in Rwanda.
J Acquir Immune Defic Syndr. 2009;50:556-8.
PubMed Text format Related articles

STEBBING J , Wong N, Tan L, Scourfield A, et al
The relationship between prolonged antiretroviral therapy and cryptogenic liver disease.
J Acquir Immune Defic Syndr. 2009;50:554-6.
PubMed Text format Related articles

READ JS , Mwatha A, Richardson B, Valentine M, et al
Primary HIV-1 Infection Among Infants in Sub-Saharan Africa: HPTN 024.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MIMIAGA MJ , Noonan E, Donnell D, Safren SA, et al
Childhood Sexual Abuse Is Highly Associated With HIV Risk-Taking Behavior and Infection Among MSM in the EXPLORE Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BICANIC T , Meintjes G, Rebe K, Williams A, et al
Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

THOMSON MM , Vinogradova A, Delgado E, Rakhmanova A, et al
Molecular Epidemiology of HIV-1 in St Petersburg, Russia: Predominance of Subtype A, Former Soviet Union Variant, and Identification of Intrasubtype Subclusters.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HIRBOD T , Kaldensjo T, Lopalco L, Klareskog E, et al
Abundant and Superficial Expression of C-Type Lectin Receptors in Ectocervix of Women at Risk of HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LIM A , French MA, Price P
CD4+ and CD8+ T Cells Expressing FoxP3 in HIV-Infected Patients Are Phenotypically Distinct and Influenced by Disease Severity and Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DEJESUS E , Young B, Morales-Ramirez JO, Sloan L, et al
Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HELLERINGER S , Kohler HP, Frimpong JA, Mkandawire J, et al
Increasing Uptake of HIV Testing and Counseling Among the Poorest in Sub-Saharan Countries Through Home-Based Service Provision.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ANNAN NT , Nelson M, Mandalia S, Bower M, et al
The Nucleoside Backbone Affects Durability of Efavirenz- or Nevirapine-Based Highly Active Antiretroviral Therapy in Antiretroviral-Naive Individuals.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

COSSARINI F , Galli L, Sagnelli C, Gianotti N, et al
Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SACHDEV DD , Zerhouni-Layachi B, Ortigoza M, Profy AT, et al
The Differential Binding and Activity of PRO 2000 Against Diverse HIV-1 Envelopes.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

ARRIBAS JR , Delgado R, Arranz A, Munoz R, et al
Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LYIMO MA , Howell AL, Balandya E, Eszterhas SK, et al
Innate Factors in Human Breast Milk Inhibit Cell-Free HIV-1 but Not Cell-Associated HIV-1 Infection of CD4+ Cells.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SENSION M , Neto JL, Grinsztejn B, Molina JM, et al
Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VIRGILI N , Fisac C, Martinez E, Ribera E, et al
Proinflammatory Cytokine Changes in Clinically Stable, Virologically Suppressed, HIV-Infected Patients Switching From Protease Inhibitors to Abacavir.
J Acquir Immune Defic Syndr. 2009;50:552-553.
PubMed Text format Related articles

PERISSE AR , Schechter M, Blattner W
Association Between Male Circumcision and Prevalent HIV Infections in Rio de Janeiro, Brazil.
J Acquir Immune Defic Syndr. 2009;50:435-437.
PubMed Text format Related articles

MASSE BR , Boily MC, Desai K
Using mathematical modeling to bridge phase 3 microbicide trials with public health decision making.
J Acquir Immune Defic Syndr. 2009;50:434-5.
PubMed Text format Related articles

ROU K , Guan J, Wu Z, Li L, et al
Demographic and Behavioral Factors Associated With HIV Testing in China.
J Acquir Immune Defic Syndr. 2009;50:432-434.
PubMed Text format Related articles

CALZA L , Pocaterra D, Pavoni M, Colangeli V, et al
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls.
J Acquir Immune Defic Syndr. 2009;50:430-432.
PubMed Text format Related articles

BANI-SADR F , Lapidus N, Rosenthal E, Gerard L, et al
Gamma Glutamyl Transferase Elevation in HIV/Hepatitis C Virus-Coinfected Patients During Interferon-Ribavirin Combination Therapy.
J Acquir Immune Defic Syndr. 2009;50:429-430.
PubMed Text format Related articles

AMIEL C , Legoff J, Lescure FX, Coste-Burel M, et al
Epstein-Barr Virus Load in Whole Blood Correlates With HIV Surrogate Markers and Lymphoma: A French National Cross-Sectional Study.
J Acquir Immune Defic Syndr. 2009;50:427-429.
PubMed Text format Related articles

UNGE C , Sodergard B, Ekstrom AM, Carter J, et al
Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya.
J Acquir Immune Defic Syndr. 2009;50:397-402.
PubMed Text format Related articles Abstract available

March 2009

SIIKA AM , Nyandiko WM, Mwangi A, Waxman M, et al
The Structure and Outcomes of a HIV Postexposure Prophylaxis Program in a High HIV Prevalence Setup in Western Kenya.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MERCIER S , Gueye NF, Cournil A, Fontbonne A, et al
Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SOBELA F , Pepin J, Gbeleou S, Banla AK, et al
A Tale of Two Countries: HIV Among Core Groups in Togo.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HENDRICKSON SL , Kingsley LA, Ruiz-Pesini E, Poole JC, et al
Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

RAISZADEH F , Hoover DR, Lee I, Shi Q, et al
Plasma Homocysteine Is Not Associated With HIV Serostatus or Antiretroviral Therapy in Women.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MUSINGUZI J , Kirungi W, Opio A, Montana L, et al
Comparison of HIV Prevalence Estimates From Sentinel Surveillance and a National Population-Based Survey in Uganda, 2004-2005.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

EMMANUEL F , Archibald C, Razaque A, Sandstrom P, et al
Factors Associated With an Explosive HIV Epidemic Among Injecting Drug Users in Sargodha, Pakistan.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CUEVAS MT , Munoz-Nieto M, Thomson MM, Delgado E, et al
HIV-1 Transmission Cluster With T215D Revertant Mutation Among Newly Diagnosed Patients From the Basque Country, Spain.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHOPRA M , Townsend L, Johnston L, Mathews C, et al
Estimating HIV Prevalence and Risk Behaviors Among High-Risk Heterosexual Men With Multiple Sex Partners: Use of Respondent-Driven Sampling.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BUSSMANN H , Wester CW, Thomas A, Novitsky V, et al
Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MAVANDADI S , Zanjani F, Ten Have TR, Oslin DW, et al
Psychological Well-Being Among Individuals Aging With HIV: The Value of Social Relationships.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NACHEGA JB , Hislop M, Nguyen H, Dowdy DW, et al
Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CROSS SJ , Rodman JH, Lindsey JC, Robbins BL, et al
Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BROTHERS CH , Hernandez JE, Cutrell AG, Curtis L, et al
Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PASSAES CB , Guimaraes ML, Fernandez SL, Lorete RD, et al
Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SCHIFFER JT , Sterling T
Response to "A Brazilian Experience in Response to Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis".
J Acquir Immune Defic Syndr. 2009;50:341.
PubMed Text format Related articles

LAWN SD , Wood R
Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis: A Reply.
J Acquir Immune Defic Syndr. 2009;50:341-342.
PubMed Text format Related articles

SCHMALTZ CA , Lopes GS, Rolla VC
A Brazilian Experience in Response to "Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis"
J Acquir Immune Defic Syndr. 2009;50:340.
PubMed Text format Related articles

AMOR A , Simon A, Salgado M, Rodes B, et al
Lack of Significant Cross-Reactivity for HIV-2 Immunoblots in HIV-1-Infected Patients.
J Acquir Immune Defic Syndr. 2009;50:339-40.
PubMed Text format Related articles

AGHDASSI E , Bondar H, Salit IE, Tinmouth J, et al
Assessment of Knowledge and Attitudes of Physicians Involved in the Care of HIV-Infected Patients With Respect to Nutrition and Nutritional Supplements.
J Acquir Immune Defic Syndr. 2009;50:337-9.
PubMed Text format Related articles

HARRIS M , Cote H, Ochoa C, Allavena C, et al
A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2009;50:335-337.
PubMed Text format Related articles

PAPASAVVAS E , Foulkes A, Li X, Kostman JR, et al
Evidence of a Decrease in CD4 Recovery Once Back on Antiretroviral Therapy After Sequential >/=6 Weeks Antiretroviral Therapy Interruptions.
J Acquir Immune Defic Syndr. 2009;50:334-335.
PubMed Text format Related articles

February 2009

RICCI E , Malacrida S, Zanchetta M, Montagna M, et al
Role of beta-Defensin-1 Polymorphisms in Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LIMA V , Harrigan R, Montaner JS
Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CRUM-CIANFLONE N , Dilay A, Collins G, Asher D, et al
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

INWANI I , Mbori-Ngacha D, Nduati R, Obimbo E, et al
Performance of Clinical Algorithms for HIV-1 Diagnosis and Antiretroviral Initiation Among HIV-1-Exposed Children Aged Less Than 18 Months in Kenya.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GATHE J , Silva BA, Cohen DE, Loutfy MR, et al
A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LIMA VD , Harrigan R, Bangsberg DR, Hogg RS, et al
The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHASOMBAT S , McConnell MS, Siangphoe U, Yuktanont P, et al
National Expansion of Antiretroviral Treatment in Thailand, 2000-2007: Program Scale-Up and Patient Outcomes.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SHAH S , Demissie M, Lambert L, Ahmed J, et al
Intensified Tuberculosis Case Finding Among HIV-Infected Persons From a Voluntary Counseling and Testing Center in Addis Ababa, Ethiopia.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SAMARAS K
Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

REN Y , Nuttall JJ, Eley BS, Meyers TM, et al
Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

NOTTET HS , van Dijk SJ, Fanoy EB, Goedegebuure IW, et al
HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SCHROECKSNADEL K , Winkler C, Sarcletti M, Romani N, et al
Parameters of Soluble Immune Activation In Vivo Correlate Negatively With the Proliferative Capacity of Peripheral Blood Mononuclear Cells In Vitro in HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KAVASERY R , Galai N, Astemborski J, Lucas GM, et al
Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WALMSLEY S , Avihingsanon A, Slim J, Ward DJ, et al
Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHEN MY , Millwood IY, Wand H, Poynten M, et al
A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

KOWALSKI J , Gange SJ, Schneider MF, Tsai HL, et al
Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

PODZAMCZER D , Olmo M, Sanz J, Boix V, et al
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SAJADI MM , Constantine NT, Mann DL, Charurat M, et al
Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral Suppressors.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CAILHOL J , Jourdain G, Coeur SL, Traisathit P, et al
Association of Low CD4 Cell Count and Intrauterine Growth Retardation in Thailand.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WANG L , Wang N, Wang L, Li D, et al
The 2007 Estimates for People at Risk for and Living With HIV in China: Progress and Challenges.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN DER STRATEN A , Shiboski S, Montgomery ET, Moore J, et al
Patterns and Predictors of Adherence to Diaphragm Use in a Phase III Trial in Sub-Saharan Africa: A Trajectory Analysis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DONAHOE RM , O'neil SP, Marsteller FA, Novembre FJ, et al
Probable Deceleration of Progression of Simian AIDS Affected by Opiate Dependency: Studies With a Rhesus Macaque/SIVsmm9 Model.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SKOWRON G , Spritzler JG, Weidler J, Robbins GK, et al
Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

GOETZ MB , Leduc R, Kostman JR, Labriola AM, et al
Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

APUZZO LG , Vaida F, Gallant JE, Ernstrom KB, et al
Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CHANG LW , Alamo S, Guma S, Christopher J, et al
Two-Year Virologic Outcomes of an Alternative AIDS Care Model: Evaluation of a Peer Health Worker and Nurse-Staffed Community-Based Program in Uganda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

POLITCH JA , Mayer KH, Anderson DJ
Depletion of CD4+ T Cells in Semen During HIV Infection and their Restoration following Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HAAS DW , Koletar SL, Laughlin L, Kendall MA, et al
Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DE LA FUENTE JS , Granja V, Escobar I, de la Fuente EC, et al
Study of the Gastrointestinal Tolerance of a New Tablet Formulation of the Lopinavir/Ritonavir Antiretroviral in HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DESQUILBET L , Margolick JB, Fried LP, Phair JP, et al
Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FALSTER K , Petoumenos K, Chuah J, Mijch A, et al
Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral Suppression.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FREW PM , Rio CD, Lu L, Clifton S, et al
Understanding Differences in Enrollment Outcomes Among High-Risk Populations Recruited to a Phase IIb HIV Vaccine Trial.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

HELMS DJ , Weinstock HS, Mahle KC, Bernstein KT, et al
HIV Testing Frequency Among Men Who Have Sex With Men Attending Sexually Transmitted Disease Clinics: Implications for HIV Prevention and Surveillance.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARTINSON N , Mohapi L, Bakos D, Gray GE, et al
Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MILANESE M , Segat L, Arraes LC, Garzino-Demo A, et al
Copy Number Variation of Defensin Genes and HIV Infection in Brazilian Children.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BANI-SADR F , Bedossa P, Rosenthal E, Merrien D, et al
Does Early Antiretroviral Treatment Prevent Liver Fibrosis in HIV/HCV-Coinfected Patients?
J Acquir Immune Defic Syndr. 2009;50:234-236.
PubMed Text format Related articles

CAPETTI AF , Piconi S, Landonio S, Rizzardini G, et al
Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?
J Acquir Immune Defic Syndr. 2009;50:233-4.
PubMed Text format Related articles

PATEL AK , Patel KK, Sharma R, Ranjan RR, et al
Prevention of Mother-to-Child HIV Transmission Using 3-Drug Combination Antiretroviral Treatment: Observational Cohort in Clinical Practice Setting in India.
J Acquir Immune Defic Syndr. 2009;50:231-3.
PubMed Text format Related articles

HOLTGRAVE D , Hall HI, Rhodes PH, Wolitski R, et al
Updated annual HIV transmission rates in the United States, 1977-2006.
J Acquir Immune Defic Syndr. 2009;50:236-8.
PubMed Text format Related articles

SULLIVAN SG , Ma W, Duan S, Li F, et al
Attitudes towards circumcision among Chinese men.
J Acquir Immune Defic Syndr. 2009;50:238-40.
PubMed Text format Related articles

January 2009

DING M , Tarwater P, Rodriguez M, Chatterjee R, et al
Estimation of the Predictive Role of Plasma Viral Load on CD4 Decline in HIV-1 Subtype C-Infected Subjects in India.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VERHOFSTEDE C , Vandekerckhove L, Eygen VV, Demecheleer E, et al
CXCR4-Using HIV Type 1 Variants Are More Commonly Found in Peripheral Blood Mononuclear Cell DNA Than in Plasma RNA.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

CAO W , Jamieson BD, Hultin LE, Hultin PM, et al
Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VELASCO M , Castilla V, Sanz J, Gaspar G, et al
Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VAN VONDEREN MG , Smulders YM, Stehouwer CD, Danner SA, et al
Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

BUTLER LM , Osmond DH, Jones AG, Martin JN, et al
Use of Saliva as a Lubricant in Anal Sexual Practices Among Homosexual Men.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

VIDELA S , Darwich L, Canadas MP, Paredes R, et al
Epidemiological Data of Different Human Papillomavirus Genotypes in Cervical Specimens of HIV-1-Infected Women Without History of Cervical Pathology.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MARU DS , Bruce RD, Walton M, Springer SA, et al
Persistence of Virological Benefits Following Directly Administered Antiretroviral Therapy Among Drug Users: Results From a Randomized Controlled Trial.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

LEVIN MJ , Anderson JP, Seage GR 3rd, Williams PL, et al
Short-Term and Long-Term Effects of Highly Active Antiretroviral Therapy on the Incidence of Herpes Zoster in HIV-Infected Children.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

SPAGNUOLO V , Gianotti N, Seminari E, Galli L, et al
Changes in Darunavir/r Resistance Score After Previous Failure to Tipranavir/r in HIV-1-Infected Multidrug-Resistant Patients.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DELUCA A , Chaisson RE, Martinson NA
Intensified Case Finding for Tuberculosis in Prevention of Mother-to-Child Transmission Programs: A Simple and Potentially Vital Addition for Maternal and Child Health.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles

VAN GEERTRUYDEN JP , Mulenga M, Chalwe V, Michael N, et al
Impact of HIV-1 Infection on the Hematological Recovery After Clinical Malaria.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

FONTAS E , Kousignian I, Pradier C, Duvivier C, et al
Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients; Results From FHDH ANRS CO4.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

WONG LH , Rooyen HV, Modiba P, Richter L, et al
Test and Tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept).
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

DELVAUX T , Elul B, Ndagije F, Munyana E, et al
Determinants of Nonadherence to a Single-Dose Nevirapine Regimen for the Prevention of Mother-to-Child HIV Transmission in Rwanda.
J Acquir Immune Defic Syndr. 2009.
PubMed Text format Related articles Abstract available

MUGAVERO MJ , Lin HY, Allison JJ, Giordano TP, et al
Racial disparities in HIV virologic failure: do missed visits matter?
J Acquir Immune Defic Syndr. 2009;50:100-8.
PubMed Text format Related articles Abstract available

BAUM MK , Rafie C, Lai S, Sales S, et al
Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
J Acquir Immune Defic Syndr. 2009;50:93-9.
PubMed Text format Related articles Abstract available

POWELL RL , Urbanski MM, Burda S, Kinge T, et al
High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa.
J Acquir Immune Defic Syndr. 2009;50:84-92.
PubMed Text format Related articles Abstract available

MIMIAGA MJ , Case P, Johnson CV, Safren SA, et al
Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.
J Acquir Immune Defic Syndr. 2009;50:77-83.
PubMed Text format Related articles Abstract available

NOVITSKY V , Woldegabriel E, Kebaabetswe L, Rossenkhan R, et al
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.
J Acquir Immune Defic Syndr. 2009;50:65-76.
PubMed Text format Related articles Abstract available

ABERG JA
Cardiovascular complications in HIV management: past, present, and future.
J Acquir Immune Defic Syndr. 2009;50:54-64.
PubMed Text format Related articles Abstract available

GIBERT CL , Shlay JC, Sharma S, Bartsch G, et al
Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy.
J Acquir Immune Defic Syndr. 2009;50:44-53.
PubMed Text format Related articles Abstract available

GANDHI NR , Moll AP, Lalloo U, Pawinski R, et al
Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
J Acquir Immune Defic Syndr. 2009;50:37-43.
PubMed Text format Related articles Abstract available

JOYCE VR , Barnett PG, Bayoumi AM, Griffin SC, et al
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
J Acquir Immune Defic Syndr. 2009;50:27-36.
PubMed Text format Related articles Abstract available

MADEC Y , Boufassa F, Avettand-Fenoel V, Hendou S, et al
Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort.
J Acquir Immune Defic Syndr. 2009;50:19-26.
PubMed Text format Related articles Abstract available

KASSAYE S , Johnston E, McColgan B, Kantor R, et al
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.
J Acquir Immune Defic Syndr. 2009;50:9-18.
PubMed Text format Related articles Abstract available

LUO M , Liu H, Zhuang K, Liu L, et al
Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.
J Acquir Immune Defic Syndr. 2009;50:1-8.
PubMed Text format Related articles Abstract available

December 2008

PERCIACCANTE A , Zanette G, Donadon V
Type 2 diabetes mellitus and increased prevalence of hepatocarcinoma in HIV-infected population.
J Acquir Immune Defic Syndr. 2008;49:573.
PubMed Text format Related articles

COHAN D , Sarnquist C, Gomez E, Feakins C, et al
Increased uptake of HIV testing with the integration of nurse-initiated HIV testing into routine prenatal care.
J Acquir Immune Defic Syndr. 2008;49:571-3.
PubMed Text format Related articles

DJOMAND G , Beyrer C, Buchbinder S
Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.
J Acquir Immune Defic Syndr. 2008;49:570.
PubMed Text format Related articles

GODY JC , Charpentier C, Mbitikon O, Si-Mohamed A, et al
High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.
J Acquir Immune Defic Syndr. 2008;49:566-9.
PubMed Text format Related articles

DE MEYER S , Hill A, Picchio G, DeMasi R, et al
Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
J Acquir Immune Defic Syndr. 2008;49:563-4.
PubMed Text format Related articles

KIDDER DP , Wolitski RJ, Pals SL, Campsmith ML, et al
Housing status and HIV risk behaviors among homeless and housed persons with HIV.
J Acquir Immune Defic Syndr. 2008;49:451-5.
PubMed Text format Related articles Abstract available

LATKIN CA , Buchanan AS, Metsch LR, Knight K, et al
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
J Acquir Immune Defic Syndr. 2008;49:447-50.
PubMed Text format Related articles Abstract available

FRIEDMAN SR , Bolyard M, Khan M, Maslow C, et al
Group sex events and HIV/STI risk in an urban network.
J Acquir Immune Defic Syndr. 2008;49:440-6.
PubMed Text format Related articles Abstract available

CHIGWEDERE P , Seage GR 3rd, Gruskin S, Lee TH, et al
Estimating the lost benefits of antiretroviral drug use in South Africa.
J Acquir Immune Defic Syndr. 2008;49:410-5.
PubMed Text format Related articles Abstract available

DELANY S , Rosas R, Mlaba N, Clayton T, et al
Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions.
J Acquir Immune Defic Syndr. 2008;49:406-9.
PubMed Text format Related articles Abstract available

HSIEH YH , Rothman RE, Bartlett JG, Yang S, et al
HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections.
J Acquir Immune Defic Syndr. 2008;49:398-405.
PubMed Text format Related articles Abstract available

NJAMNSHI AK , Djientcheu Vde P, Fonsah JY, Yepnjio FN, et al
The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaounde-Cameroon.
J Acquir Immune Defic Syndr. 2008;49:393-7.
PubMed Text format Related articles Abstract available

TIEN PC , Schneider MF, Cole SR, Levine AM, et al
Antiretroviral therapy exposure and insulin resistance in the women's interagency HIV study.
J Acquir Immune Defic Syndr. 2008;49:369-76.
PubMed Text format Related articles Abstract available

KNOX TA , Oleson L, von Moltke LL, Kaufman RC, et al
Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis.
J Acquir Immune Defic Syndr. 2008;49:358-68.
PubMed Text format Related articles Abstract available

USUGA X , Montoya CJ, Landay AL, Rugeles MT, et al
Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.
J Acquir Immune Defic Syndr. 2008;49:348-57.
PubMed Text format Related articles Abstract available

PATTANAPANYASAT K , Phuang-Ngern Y, Sukapirom K, Lerdwana S, et al
Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resource-limited settings.
J Acquir Immune Defic Syndr. 2008;49:339-47.
PubMed Text format Related articles Abstract available

DE BOER-VAN DER KOLK IM , Sprangers MA, van der Ende M, Schreij G, et al
Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
J Acquir Immune Defic Syndr. 2008;49:460-2.
PubMed Text format Related articles

November 2008

ROBERTSON SM , Maldarelli F, Natarajan V, Formentini E, et al
Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects.
J Acquir Immune Defic Syndr. 2008.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: